EYES - セカンド・サイト・メディカル・プロダクト （Second Sight Medical Products Inc.）

Second Sight Medical Products (EYES) said it completed its merger with Nano Precision Medical, and has changed its name to Vivani Medical Inc.The company''s common stock will trade…

Second Sight Medical Products, Inc. (EYES), a maker of implantable visual prosthetics, dropped ~17% on Friday morning as its shares began trading on a split-adjusted basis following…

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced results of its annual meeting held on July 27, 2022, where the quorum was present. The formal results of the vote are included in a Current Report on

Second Sight Medical Products (EYES) said it completed its merger with Nano Precision Medical, and has changed its name to Vivani Medical Inc.The company''s common stock will trade…

Second Sight Medical Products, Inc. (EYES), a maker of implantable visual prosthetics, dropped ~17% on Friday morning as its shares began trading on a split-adjusted basis following…

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced results of its annual meeting held on July 27, 2022, where the quorum was present. The formal results of the vote are included in a Current Report on

CONMED (NYSE:CNMD) and Second Sight Medical Products (NASDAQ:EYES) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, dividends, valuation and earnings. Analyst Recommendations This is a summary of recent ratings for CONMED and Second Sight Medical []

State Street Corp purchased a new stake in shares of Second Sight Medical Products, Inc. in the 2nd quarter, according to the company in its most recent Form 13F filing with

State Street Corp purchased a new stake in shares of Second Sight Medical Products, Inc. (NASDAQ:EYES) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 92,394 shares of the medical device companys stock, valued at approximately $456,000. State Street Corp owned 0.24% [] The post State Street Corp Buys New Shares in Second Sight Medical Products, Inc. (NASDAQ:EYES) appeared first on ETF Daily News .

Northern Trust Corp increased its holdings in shares of Second Sight Medical Products, Inc. (NASDAQ:EYES) by 33.7% in the second quarter, according to its most recent filing with the SEC. The fund owned 34,658 shares of the medical device companys stock after acquiring an additional 8,735 shares during the period. Northern Trust Corps holdings in [] The post Northern Trust Corp Increases Stock Holdings in Second Sight Medical Products, Inc. (NASDAQ:EYES) appeared first on ETF Daily News .

Geode Capital Management LLC grew its position in Second Sight Medical Products, Inc. (NASDAQ:EYES) by 36.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 146,527 shares of the medical device companys stock after acquiring an additional 39,151 shares during the quarter. Geode Capital Management []